Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

被引：0
|
作者：
Adeniyi Olagunju
Adeola Fowotade
Ajibola Olagunoye
Temitope Olumuyiwa Ojo
Bolanle Olufunlola Adefuye
Adeniyi Francis Fagbamigbe
Akindele Olupelumi Adebiyi
Omobolanle Ibitayo Olagunju
Olabode Taiwo Ladipo
Abdulafeez Akinloye
Babatunde Ayodeji Adeagbo
Adedeji Onayade
Oluseye Oladotun Bolaji
Christian Happi
Steve Rannard
Andrew Owen
机构：
[1] Obafemi Awolowo University,Department of Pharmaceutical Chemistry, Faculty of Pharmacy
[2] University of Liverpool,Department of Molecular and Clinical Pharmacology
[3] University of Ibadan,Department of Medical Microbiology and Parasitology, College of Medicine
[4] State Specialist Hospital,Department of Community Health, Faculty of Clinical Sciences
[5] Obafemi Awolowo University Teaching Hospital,Department of Epidemiology and Medical Statistics, Faculty of Public Health
[6] Olabisi Onabanjo University Teaching Hospital,Department of Community Medicine
[7] University of Ibadan,Department of Surveillance and Epidemiology
[8] University of Ibadan,African Centre of Excellence for Genomics of Infectious Diseases
[9] Nigeria Centre for Disease Control,Department of Chemistry, School of Physical Sciences
[10] Oyo State Ministry of Health,undefined
[11] Redeemer’s University,undefined
[12] University of Liverpool,undefined
来源：
Trials | / 22卷
关键词：
COVID-19; SARS-CoV-2; nitazoxanide; atazanavir/ritonavir; randomised controlled trial; protocol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial
    Allahyari, Abolghasem
    Rahimi, Hossein
    Khadem-Rezaiyan, Majid
    Mozaheb, Zahra
    Seddigh-Shamsi, Mohsen
    Bary, Alireza
    Kamandi, Mostafa
    Azimi, Sajad Ataei
    HasanAbadi, Saeed Eslami
    Noferesti, Alireza
    Shariatmaghani, Somayeh Sadat
    Rafatpanah, Houshang
    Khatami, Shohreh
    Imani, Afshin Jabbar
    Mortazi, Hassan
    Nodeh, Mohammad Moeini
    TRIALS, 2020, 21 (01)
  • [32] Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial
    Abolghasem Allahyari
    Hossein Rahimi
    Majid Khadem-Rezaiyan
    Zahra Mozaheb
    Mohsen Seddigh-Shamsi
    Alireza Bary
    Mostafa Kamandi
    Sajad Ataei Azimi
    Saeed Eslami HasanAbadi
    Alireza Noferesti
    Somayeh Sadat Shariatmaghani
    Houshang Rafatpanah
    Shohreh Khatami
    Afshin Jabbar Imani
    Hassan Mortazi
    Mohammad Moeini Nodeh
    Trials, 21
  • [33] Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Ziaei, Ava
    Davoodian, Parivash
    Dadvand, Habib
    Safa, Omid
    Hassanipour, Soheil
    Omidi, Mahmoud
    Masjedi, Moein
    Mahmoudikia, Fahime
    Rafiee, Bahareh
    Fathalipour, Mohammad
    TRIALS, 2020, 21 (01)
  • [34] Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Ava Ziaei
    Parivash Davoodian
    Habib Dadvand
    Omid Safa
    Soheil Hassanipour
    Mahmoud Omidi
    Moein Masjedi
    Fahime Mahmoudikia
    Bahareh Rafiee
    Mohammad Fathalipour
    Trials, 21
  • [35] Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
    Rosario Garcia-Vicuña
    Francisco Abad-Santos
    Isidoro González-Alvaro
    Francisco Ramos-Lima
    Jesús Sanz Sanz
    Trials, 21
  • [36] Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
    Garcia-Vicuna, Rosario
    Abad-Santos, Francisco
    Gonzalez-Alvaro, Isidoro
    Ramos-Lima, Francisco
    Sanz, Jesus Sanz
    TRIALS, 2020, 21 (01)
  • [37] Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial
    Hrishikesh Rangnekar
    Suresh Patankar
    Kishor Suryawanshi
    Pravin Soni
    Trials, 21
  • [38] Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial
    Rangnekar, Hrishikesh
    Patankar, Suresh
    Suryawanshi, Kishor
    Soni, Pravin
    TRIALS, 2020, 21 (01)
  • [39] An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
    McMahon, James H.
    Lau, Jillian S. Y.
    Roney, Janine
    Rogers, Benjamin A.
    Trubiano, Jason
    Sasadeusz, Joseph
    Molton, James S.
    Gardiner, Bradley
    Lee, Sue J.
    Hoy, Jennifer F.
    Cheng, Allen
    Peleg, Anton Y.
    TRIALS, 2020, 21 (01)
  • [40] An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
    James H. McMahon
    Jillian S. Y. Lau
    Janine Roney
    Benjamin A. Rogers
    Jason Trubiano
    Joseph Sasadeusz
    James S. Molton
    Bradley Gardiner
    Sue J. Lee
    Jennifer F. Hoy
    Allen Cheng
    Anton Y. Peleg
    Trials, 21
12345